BSN315 Week 6 Pharm II Exam Questions
and Answers with Verified Solutions | Latest
Updated 2026
Drug Therapy for Rheumatoid
Arthritis:
A drug class that is recommended
for use to delay disease
progression
in RA is known as
disease-modifying
antirheumatic drugs (DMARDs).
nonbiologic
DMARDs:Methotrexate,
leflunomide, and tofacitinib
biologic DMARDs: Etanercept and
abatacept
,Question 1 of 4 Biologic disease-modifying antirheumatic
Which drug classes are used in drugs
the (DMARDs)
management of rheumatoid Glucocorticoids
arthritis Nonbiologic DMARDs
(RA)? Nonsteroidal antiinflammatory drugs
Select all that apply. (NSAIDs)
Biologic disease-modifying
antirheumatic drugs (DMARDs)
Glucocorticoids
Mineralocorticoids
Nonbiologic DMARDs
Nonsteroidal antiinflammatory
drugs
(NSAIDs)
Question 2 of 4 Methotrexate
Which disease-modifying Hydroxychloroquine
antirheumatic drugs (DMARDs)
are
considered nonbiologic?
Select all that apply.
Anakinra
Abatacept
Etanercept
Tocilizumab
Methotrexate
Hydroxychloroquine
,Question 3 of 4 Leflunomide
Which disease-modifying Leflunomide is a highly protein-bound
antirheumatic drug (DMARD) is drug, with
highly protein bound (99%)? an estimated protein binding of 99%.
Abatacept
Leflunomide
Methotrexate
Tofacitinib
Question 4 of 4 3 to 6 weeks
Which time frame accurately Methotrexate has a delayed onset of
describes methotrexate's onset of action of 3 to
action? 6 weeks.
0.5 to 1 hour
1 to 2 hours
3 to 10 hours
3 to 6 weeks
, Patient teaching: about
compliance,
administration, side effects, and
adverse effects must be performed
to ensure the safety of patients
taking DMARDs.
-Given that DMARDs have
immunosuppressive effects,
educate
the patient about signs and
symptoms of an infection (e.g.,
fever
of 100.5°F [38.1°C] or higher,
nausea,
vomiting, diarrhea, sore throat)
and
the importance of reporting this
immediately to the health care
provider.
-Pregnant women should not
receive
therapy with methotrexate and
leflunomide. Educate female
patients
of childbearing age about methods
of contraception and the need to
use contraception for extended
periods after discontinuation of
therapy (depending on drug
choice).
Educate male patients about the
risks of pregnancy in female
partners
that may occur up to 3 months
after
methotrexate discontinuation.
and Answers with Verified Solutions | Latest
Updated 2026
Drug Therapy for Rheumatoid
Arthritis:
A drug class that is recommended
for use to delay disease
progression
in RA is known as
disease-modifying
antirheumatic drugs (DMARDs).
nonbiologic
DMARDs:Methotrexate,
leflunomide, and tofacitinib
biologic DMARDs: Etanercept and
abatacept
,Question 1 of 4 Biologic disease-modifying antirheumatic
Which drug classes are used in drugs
the (DMARDs)
management of rheumatoid Glucocorticoids
arthritis Nonbiologic DMARDs
(RA)? Nonsteroidal antiinflammatory drugs
Select all that apply. (NSAIDs)
Biologic disease-modifying
antirheumatic drugs (DMARDs)
Glucocorticoids
Mineralocorticoids
Nonbiologic DMARDs
Nonsteroidal antiinflammatory
drugs
(NSAIDs)
Question 2 of 4 Methotrexate
Which disease-modifying Hydroxychloroquine
antirheumatic drugs (DMARDs)
are
considered nonbiologic?
Select all that apply.
Anakinra
Abatacept
Etanercept
Tocilizumab
Methotrexate
Hydroxychloroquine
,Question 3 of 4 Leflunomide
Which disease-modifying Leflunomide is a highly protein-bound
antirheumatic drug (DMARD) is drug, with
highly protein bound (99%)? an estimated protein binding of 99%.
Abatacept
Leflunomide
Methotrexate
Tofacitinib
Question 4 of 4 3 to 6 weeks
Which time frame accurately Methotrexate has a delayed onset of
describes methotrexate's onset of action of 3 to
action? 6 weeks.
0.5 to 1 hour
1 to 2 hours
3 to 10 hours
3 to 6 weeks
, Patient teaching: about
compliance,
administration, side effects, and
adverse effects must be performed
to ensure the safety of patients
taking DMARDs.
-Given that DMARDs have
immunosuppressive effects,
educate
the patient about signs and
symptoms of an infection (e.g.,
fever
of 100.5°F [38.1°C] or higher,
nausea,
vomiting, diarrhea, sore throat)
and
the importance of reporting this
immediately to the health care
provider.
-Pregnant women should not
receive
therapy with methotrexate and
leflunomide. Educate female
patients
of childbearing age about methods
of contraception and the need to
use contraception for extended
periods after discontinuation of
therapy (depending on drug
choice).
Educate male patients about the
risks of pregnancy in female
partners
that may occur up to 3 months
after
methotrexate discontinuation.
